Understanding Chronic Lymphocytic Leukemia
NCT04028531 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2750
Last updated 2026-04-24
Summary
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.
Conditions
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH - lead OTHER
Principal Investigators
-
Jennifer Brown, MD,PhD · Dana-Farber Cancer Institute
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-09-29
- Primary Completion
- 2030-09-29
- Completion
- 2032-09-29
Countries
- United States
Study Locations
More Related Trials
-
Genotyping Analysis of Acute Lymphoblastic Leukemia
NCT00961285 ·Status: UNKNOWN
-
An Observational Study on The Health Related Quality of Life in Patients With Chronic Lymphocytic Leukaemia
NCT01395615 ·Status: COMPLETED
-
Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia
NCT01649791 ·Status: TERMINATED ·Phase: NA
-
Study of the Immunological Infiltrate and Immunometabolic Immunometabolic Profile of Patients with Acute Leukaemia
NCT06814444 ·Status: RECRUITING
-
Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT00439231 ·Status: COMPLETED ·Phase: PHASE2
-
Real-World Disease Management and Outcomes in Chronic Myeloid Leukaemia
NCT05893836 ·Status: COMPLETED
-
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT01185886 ·Status: UNKNOWN
-
Vaccine Responsiveness in Patients With Chronic Lymphocytic Leukemia
NCT05007860 ·Status: COMPLETED
-
Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic Leukemia
NCT01271283 ·Status: WITHDRAWN ·Phase: PHASE2
-
Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia
NCT00006097 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
NCT00003861 ·Status: ACTIVE_NOT_RECRUITING
-
Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia
NCT00005829 ·Status: COMPLETED ·Phase: PHASE2
-
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
NCT02582879 ·Status: COMPLETED
-
Phase IV Observational Study in Chronic Lymphocytic Leukemia
NCT01453062 ·Status: COMPLETED
-
Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
NCT01732861 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of SyB L-0501 for Patients With Chronic Lymphocytic Leukemia
NCT02042911 ·Status: COMPLETED ·Phase: PHASE2
-
Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421
NCT01035307 ·Status: COMPLETED
-
Study of the Metabolism in the Lymphatic Niche of CLL
NCT05610228 ·Status: UNKNOWN
-
Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water
NCT01110850 ·Status: COMPLETED
-
Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia
NCT01625143 ·Status: COMPLETED
-
Dasatinib in Relapsed Chronic Lymphocytic Leukemia
NCT00438854 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia
NCT00126893 ·Status: TERMINATED ·Phase: PHASE1
-
Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial
NCT01004640 ·Status: UNKNOWN
-
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia
NCT00898092 ·Status: UNKNOWN
-
Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
NCT00751296 ·Status: TERMINATED ·Phase: PHASE2